SGX Google Yahoo TradingView

IX BIOPHARMA LTD. W260718 (HQXW) SGD 0.305   -1.64% -0.01

Portfolio Watchlist
AllFinancialBuy BackInsider Trading

IX BiopharmaW260718

2026-05-02
General Announcement::Question and Answer Ahead of the Upcoming Extraordinary General Meeting to Be Held on 8 May 2026

IX BiopharmaW260718

2026-04-30
General Announcement::Proposed Placement of 1,349,434 New Ordinary Shares to Anson Properties & Directors - Receipt of LQN

IX BiopharmaW260718

2026-04-17
Employee Stock Option/ Share Scheme::Grant of Share Awards Pursuant to iX Performance Share Plan

IX BiopharmaW260718

2026-04-15
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Eddy Lee Yip Hang

IX BiopharmaW260718

2026-04-10
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Changes in Interest by Substantial Shareholder - Anson Properties Pte. Ltd.

IX BiopharmaW260718

2026-04-10
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Eddy Lee Yip Hang

IX BiopharmaW260718

2026-04-09
General Announcement::Chairman & CEO Invests S$600,000 as Warrant Conversions Gain Momentum

IX BiopharmaW260718

2026-04-05
General Announcement::Corporate Presentation for CLSA & SGX Singapore SMID-Cap Access Day

IX BiopharmaW260718

2026-02-26
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Changes in Interest by Substantial Shareholder - Eddy Lee Yip Hang

IX BiopharmaW260718

2026-02-24
Placements::Proposed Placement to Raise Gross Proceeds No Less Than S$6,000,000 - Proposed Placement Completion

IX BiopharmaW260718

2026-02-19
Placements::Proposed Placement to Raise Gross Proceeds No Less Than S$6,000,000 - Receipt of LQN

IX BiopharmaW260718

2026-02-13
General Announcement::Request for Lifting of Trading Halt - Sponsor's Statement

IX BiopharmaW260718

2026-02-13
Request for Lifting of Trading Halt::Request for Lifting of Trading Halt

IX BiopharmaW260718

2026-02-13
Placements::Proposed Placement to Raise Gross Proceeds No Less Than S$6,000,000 - Results of Proposed Placement

IX BiopharmaW260718

2026-02-12
General Announcement::Proposed Placement to Raise Gross Proceeds of No Less Than S$6,000,000 - Entry Into Placement Agrt

IX BiopharmaW260718

2026-02-12
General Announcement::Press Release - iX Biopharma Awarded US$41 Million U.S. Government Contract

IX BiopharmaW260718

2026-02-12
General Announcement::U.S. Government Awards IX Biopharma US$41 Million Contract to Fund Development of Wafermine

IX BiopharmaW260718

2026-02-11
Request for Trading Halt::Request for Trading Halt

IX BiopharmaW260718

2026-02-08
Financial Statements and Related Announcement::Half Yearly Results

IX BiopharmaW260718

2026-01-20
General Announcement::Press Release - iX Biopharma Named Among Singapore's Fastest Growing Companies 2026

IX BiopharmaW260718

2025-11-17
General Announcement::Minutes of Annual General Meeting Held on 24 October 2025

IX BiopharmaW260718

2025-11-09
General Announcement::Entry Into Term Sheet for Proposed JV to Establish Manufacturing and Commercialisation in USA

IX BiopharmaW260718

2025-10-31
Placements::Proposed Placement To Raise Gross Proceeds No Less Than S$5 Million - Proposed Placement Completion

IX BiopharmaW260718

2025-10-28
General Announcement::Request for Lifting of Trading Halt - Sponsor's Statement

IX BiopharmaW260718

2025-10-28
Request for Lifting of Trading Halt::Request for Lifting of Trading Halt

IX BiopharmaW260718

2025-10-27
Request for Trading Halt::Request for Trading Halt

IX BiopharmaW260718

2025-10-07
Annual Reports and Related Documents::

IX BiopharmaW260718

2025-09-30
Financial Statements and Related Announcement::Auditor's Comments of Accounts

IX BiopharmaW260718

2025-05-23
General Announcement::Notice of End of Conversion Period and Maturity Date of Convertible Bonds

IX BiopharmaW260718

2025-03-26
General Announcement::Minutes of Extraordinary General Meeting Held on 10 March 2025

IX BiopharmaW260718

2025-02-20
General Announcement::Proposed Appointment of Auditors and Proposed Issuance of Shares to Directors

IX BiopharmaW260718

2025-02-07
General Announcement::Press Release - iX Biopharma Delivers 39% Revenue Growth in 1H25, Reduces Operating Cash Burn by 33%

IX BiopharmaW260718

2024-11-19
General Announcement::Press Release - iXB 401 Achieves 20x Higher Bioavailability Than Rybelsus in Preclinical Study

IX BiopharmaW260718

2024-11-15
General Announcement::Minutes of Extraordinary General Meeting Held on 17 October 2024

IX BiopharmaW260718

2024-10-17
General Announcement::Formation of the Audit and Risk Committee and Reconstitution of the Board Committees

IX BiopharmaW260718

2024-10-14
General Announcement::Press Release - iX Biopharma Appoints Dr. Brian Kennedy as New Scientific Advisor

IX BiopharmaW260718

2024-09-16
General Announcement::Press Release - Business and Drug Development Updates - Wafermine and iXB 401

IX BiopharmaW260718

2024-09-01
General Announcement::Press Release - New Study Demonstrates that SL-NAD+ Delivers NAD+ into Cells

IX BiopharmaW260718

2024-08-23
Financial Statements and Related Announcement::Full Yearly Results

IX BiopharmaW260718

2024-07-24
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Changes in Interest by Substantial Shareholder - Anson Properties Pte. Ltd.

IX BiopharmaW260718

2024-07-24
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Eddy Lee Yip Hang

IX BiopharmaW260718

2024-07-22
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Albert Ho Shing Tung

IX BiopharmaW260718

2024-07-22
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Eddy Lee Yip Hang

IX BiopharmaW260718

2024-07-22
REPL::General Announcement::Issue and Listing of the Rights Shares and the Warrants

© 2026 Dividends.sg